Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Non-Current Liabilities (2023 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $55.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 5.19% to $55.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $55.9 million, a 5.19% increase, with the full-year FY2024 number at $50.8 million, up 23.88% from a year prior.
  • Total Non-Current Liabilities was $55.9 million for Q3 2025 at Xtant Medical Holdings, up from $54.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $55.9 million in Q3 2025 to a low of $41.0 million in Q4 2023.
  • A 3-year average of $50.5 million and a median of $51.4 million in 2024 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: increased 23.88% in 2024, then increased 5.19% in 2025.
  • Xtant Medical Holdings' Total Non-Current Liabilities stood at $41.0 million in 2023, then rose by 23.88% to $50.8 million in 2024, then grew by 9.93% to $55.9 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Total Non-Current Liabilities are $55.9 million (Q3 2025), $54.9 million (Q2 2025), and $51.9 million (Q1 2025).